ReCode Therapeutics Stock

recodetx.comHealthcareFounded: 2015Funding to Date: $307.77MM

Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.

Register for Details

For more details on financing and valuation for ReCode Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for ReCode Therapeutics.

Register Today

Other companies like ReCode Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM